Tweedy, Browne Co’s GSK GSK Stock Holding History

Tweedy, Browne Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.51M	Sell	81,785 -458	-0.6%	-$24.8K	0.36%	27
2025 Q4	$4.03M	Hold	82,243	–	–	0.33%	27
2025 Q3	$3.55M	Sell	82,243 -4,628	-5%	-$181K	0.31%	30
2025 Q2	$3.34M	Sell	86,871 -3,674	-4%	-$140K	0.31%	31
2025 Q1	$3.51M	Sell	90,545 -3,271	-3%	-$120K	0.31%	31
2024 Q4	$3.17M	Sell	93,816 -14,219	-13%	-$512K	0.21%	33
2024 Q3	$4.42M	Sell	108,035 -1,820	-2%	-$74.5K	0.21%	33
2024 Q2	$4.23M	Sell	109,855 -13,189	-11%	-$555K	0.19%	34
2024 Q1	$5.27M	Sell	123,044 -1,356	-1%	-$55.9K	0.25%	32
2023 Q4	$4.61M	Sell	124,400 -5,594	-4%	-$201K	0.23%	32
2023 Q3	$4.71M	Sell	129,994 -4,520	-3%	-$160K	0.25%	33
2023 Q2	$4.79M	Sell	134,514 -861	-0.6%	-$30.9K	0.25%	32
2023 Q1	$4.82M	Sell	135,375 -3,952	-3%	-$138K	0.26%	33
2022 Q4	$4.9M	Sell	139,327 -6,336	-4%	-$211K	0.26%	33
2022 Q3	$4.29M	Sell	145,663 -6,674	-4%	-$253K	0.19%	36
2022 Q2	$8.29M	Sell	152,337 -5,118	-3%	-$283K	0.34%	35
2022 Q1	$8.57M	Sell	157,455 -2,303	-1%	-$125K	0.28%	36
2021 Q4	$8.81M	Buy	159,758 +11,185	+8%	+$582K	0.28%	35
2021 Q3	$7.1M	Sell	148,573 -2,559	-2%	-$129K	0.24%	37
2021 Q2	$7.52M	Sell	151,132 -3,027	-2%	-$145K	0.21%	38
2021 Q1	$6.88M	Buy	154,159 +31,915	+26%	+$1.45M	0.2%	38
2020 Q4	$5.62M	Sell	122,244 -5,467	-4%	-$251K	0.17%	38
2020 Q3	$6.01M	Buy	127,711 +3,295	+3%	+$165K	0.23%	35
2020 Q2	$6.34M	Sell	124,416 -7,289	-6%	-$374K	0.25%	33
2020 Q1	$6.24M	Sell	131,705 -5,102	-4%	-$272K	0.29%	33
2019 Q4	$8.04M	Sell	136,807 -2,160	-2%	-$120K	0.29%	32
2019 Q3	$7.41M	Sell	138,967 -5,151	-4%	-$265K	0.26%	36
2019 Q2	$7.21M	Sell	144,118 -6,649	-4%	-$334K	0.25%	36
2019 Q1	$7.88M	Sell	150,767 -642	-0.4%	-$32.1K	0.26%	36
2018 Q4	$7.23M	Sell	151,409 -3,246	-2%	-$160K	0.26%	36
2018 Q3	$7.77M	Sell	154,655 -549	-0.4%	-$27.9K	0.23%	34
2018 Q2	$7.82M	Sell	155,204 -70	-0%	-$3.53K	0.24%	35
2018 Q1	$7.58M	Sell	155,274 -2,545	-2%	-$119K	0.23%	36
2017 Q4	$7M	Buy	157,819 +70,464	+81%	+$3.26M	0.19%	41
2017 Q3	$4.43M	Sell	87,355 -312	-0.4%	-$15.8K	0.12%	44
2017 Q2	$4.72M	Sell	87,667 -796	-0.9%	-$42.4K	0.14%	42
2017 Q1	$4.66M	Sell	88,463 -3,087	-3%	-$157K	0.13%	43
2016 Q4	$4.41M	Sell	91,550 -325	-0.4%	-$16.1K	0.14%	41
2016 Q3	$4.95M	Sell	91,875 -1,318	-1%	-$72.3K	0.15%	43
2016 Q2	$5.05M	Buy	93,193 +337	+0.4%	+$17.8K	0.14%	43
2016 Q1	$4.71M	Sell	92,856 -13,643	-13%	-$680K	0.13%	43
2015 Q4	$5.37M	Sell	106,499 -267	-0.3%	-$13.6K	0.16%	42
2015 Q3	$5.13M	Buy	106,766 +4,138	+4%	+$215K	0.15%	41
2015 Q2	$5.34M	Sell	102,628 -2,449	-2%	-$138K	0.15%	39
2015 Q1	$6.06M	Sell	105,077 -2,357	-2%	-$135K	0.16%	39
2014 Q4	$5.74M	Sell	107,434 -4,788	-4%	-$268K	0.15%	40
2014 Q3	$6.45M	Sell	112,222 -1,472	-1%	-$90.2K	0.15%	41
2014 Q2	$7.6M	Sell	113,694 -384	-0.3%	-$26K	0.16%	40
2014 Q1	$7.62M	Sell	114,078 -6,069	-5%	-$410K	0.18%	41
2013 Q4	$8.02M	Sell	120,147 -677	-0.6%	-$43.9K	0.19%	42
2013 Q3	$7.58M	Sell	120,824 -48	-0%	-$3.09K	0.18%	42
2013 Q2	$7.55M	Buy	+120,872	New	+$7.67M	0.19%	42

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tweedy, Browne Co's GSK Position: Q1 2026 in Review

Tweedy, Browne Co reduced its GSK (GSK) stake by 0.56% in Q1 2026, selling an estimated $24.8K and leaving 81,785 shares worth $4.51M. The position accounts for 0.36% of the portfolio, ranked #27.

Tweedy, Browne Co first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.81M in Q4 2021. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Tweedy, Browne Co held 81,785 shares of GSK worth $4.51M as of Q1 2026.
Tweedy, Browne Co sold 458 GSK shares in Q1 2026, an estimated $24.8K.
GSK made up 0.36% of Tweedy, Browne Co's portfolio in Q1 2026, its #27 holding.
Tweedy, Browne Co first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
Tweedy, Browne Co's GSK position peaked at $8.81M in Q4 2021.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Tweedy, Browne Co's 13F filing for Q1 2026, filed 6 May 2026.